|
|
|
|
| LEADER |
00000C #a2200000 #4500 |
| 001 |
INGC-PRO-00516 |
| 003 |
AR-LpUFI |
| 005 |
20220927103406.0 |
| 008 |
200912s2006 xxu|||||| 0|||||eng d |
| 040 |
|
|
|a AR-LpUFI
|b spa
|
| 245 |
0 |
0 |
|a Nanomolar cationic dendrimeric sulfadiazine as potential antitoxoplasmic agent.
|
| 700 |
1 |
|
|a Amalvy, Javier Ignacio.
|9 314855
|
| 700 |
1 |
|
|a Prieto, M.J.
|9 314856
|
| 700 |
1 |
|
|a Bacigalupe, D.
|9 314857
|
| 700 |
1 |
|
|a Pardini, Oscar R.
|9 314858
|
| 700 |
1 |
|
|a Venturini, J.
|9 314859
|
| 700 |
1 |
|
|a Morilla, M.J.
|9 314860
|
| 700 |
1 |
|
|a Romero, E.L.
|9 314861
|
| 773 |
0 |
|
|t International Journal of Pharmaceutics
|d Elsevier
|g Vol.326, Nr.1-2, pags.160-168
|x 03785173
|
| 856 |
|
|
|u http://dx.doi.org/10.1016/j.ijpharm.2006.05.068
|
| 929 |
|
|
|a Disponible version impresa y PDF en Biblioteca
|
| 942 |
|
|
|c AJO
|6 _
|
| 990 |
|
|
|a GBY
|
| 999 |
|
|
|c 26872
|d 26872
|
